U.S. flag

An official website of the United States government

NM_004360.5(CDH1):c.2530A>G (p.Ser844Gly) AND Hereditary cancer-predisposing syndrome

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Sep 28, 2019
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001015857.3

Allele description [Variation Report for NM_004360.5(CDH1):c.2530A>G (p.Ser844Gly)]

NM_004360.5(CDH1):c.2530A>G (p.Ser844Gly)

Gene:
CDH1:cadherin 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
16q22.1
Genomic location:
Preferred name:
NM_004360.5(CDH1):c.2530A>G (p.Ser844Gly)
HGVS:
  • NC_000016.10:g.68833380A>G
  • NG_008021.1:g.101089A>G
  • NM_001317184.2:c.2347A>G
  • NM_001317185.2:c.982A>G
  • NM_001317186.2:c.565A>G
  • NM_004360.5:c.2530A>GMANE SELECT
  • NP_001304113.1:p.Ser783Gly
  • NP_001304114.1:p.Ser328Gly
  • NP_001304115.1:p.Ser189Gly
  • NP_004351.1:p.Ser844Gly
  • LRG_301t1:c.2530A>G
  • LRG_301:g.101089A>G
  • NC_000016.9:g.68867283A>G
  • NM_004360.3:c.2530A>G
Protein change:
S189G
Links:
dbSNP: rs761400928
NCBI 1000 Genomes Browser:
rs761400928
Molecular consequence:
  • NM_001317184.2:c.2347A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001317185.2:c.982A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001317186.2:c.565A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_004360.5:c.2530A>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Hereditary cancer-predisposing syndrome
Synonyms:
Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001176737Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Uncertain significance
(Sep 28, 2019)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

The unsolved enigma of CDH1 down-regulation in hereditary diffuse gastric cancer.

Concolino P, Papa V, Mozzetti S, Ferlini C, Pacelli F, Martinelli E, Ricci R, Filippetti F, Scambia G, Doglietto GB.

J Surg Res. 2004 Sep;121(1):50-5.

PubMed [citation]
PMID:
15313375

Germline pathogenic variants of 11 breast cancer genes in 7,051 Japanese patients and 11,241 controls.

Momozawa Y, Iwasaki Y, Parsons MT, Kamatani Y, Takahashi A, Tamura C, Katagiri T, Yoshida T, Nakamura S, Sugano K, Miki Y, Hirata M, Matsuda K, Spurdle AB, Kubo M.

Nat Commun. 2018 Oct 4;9(1):4083. doi: 10.1038/s41467-018-06581-8.

PubMed [citation]
PMID:
30287823
PMCID:
PMC6172276

Details of each submission

From Ambry Genetics, SCV001176737.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

The p.S844G variant (also known as c.2530A>G), located in coding exon 16 of the CDH1 gene, results from an A to G substitution at nucleotide position 2530. The serine at codon 844 is replaced by glycine, an amino acid with similar properties. This alteration has been reported with a carrier frequency of 0.00028 in 7051 unselected female breast cancer patients, 0.00 in 53 unselected male breast cancer patients, 0.00018 in 11241 female controls, and 0.0002 in 12490 male controls of Japanese ancestry (Momozawa Y et al. Nat Commun, 2018 10;9:4083). This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 1, 2024